APOE gene polymorphism analysis in Barranquilla, Colombia
Abstract
Introduction: The genetic variability present in the APOE gene polymorphism is considered an important factor associated with predisposition to diseases affecting lipid metabolism, as well as heart diseases and Alzheimer’s disease, among others. Understanding it as a risk factor in different populations and ethnic groups is a useful tool. Objective: To analyze the APOE gene polymorphism and determine allelic and genotypic frequencies of a representative sample of population from Barranquilla, Colombia. Materials and methods: We performed a descriptive and comparative study. The sample size was 227 unrelated individuals from Barranquilla, Colombia. Results: The most frequent allele was the ε3, with 85%, followed by the ε4 allele (13%) and ε2 (1.8%). The genotypes found were: ε3/ε3: 71.8%, ε3/ε4: 24.2%, ε2/ε3: 2.2%, ε2/ε4: 1.3% and ε4/ε4: 0.4%. The ε2/ε2 genotype was not found in this study. The sample exhibited the Hardy-Weinberg equilibrium. Conclusion: The frequency of the ε3 allele and the ε3/ε3 genotype was similar to that reported in the literature in countries like Brazil, Mexico, Colombia, and in some Colombian Amerindian ethnic groups. The ε2/ε2 genotype was absent. This result is consistent with those found in other population groups worldwide. The frequency of the ε4 allele and the genotypes associated in this population could be related to the presence of diseases such as hypercholesterolemia, myocardial infarction and Alzheimer.
Downloads
References
Scott J, Knott TJ, Shaw DJ, Brook JD. Localization of genes encoding apolipoprotein CI, CII, and E to the p13->cen region of human chromosome 19. Hum Genet. 1985; 71 :144-6.
Das HK, McPherson J, Bruns GA, Karathanasis SK, Breslow JL. Isolation, characterization and mapping to chromosome 19 of the human apolipoprotein E gene. J Biol Chem . 1985;260:6240-7.
Paik YK, Chang DJ, Reardon CA, Davies GE, Mahley RW, Taylor JM. Nucleotide sequence and structure of the human apolipoprotein E gene. Proc Natl Acad Sci USA. 1985;82:3445-9.
Hatters DM, Peters-Libeu CA, Weisgraber KH. Apolip oprotein E structure: Insights into function. Trends Biochem Sci. 2006;31:445-54. http://dx.doi.org/10.1016/j.tibs.2006.06.008
Henry JB. El laboratorio en el diagnóstico clínico. Madrid: Marban; 2005.
Feng J, Xiang L, Wan G, Qi K, Sun L, Huang Z, et al . Is APOE e3 a favourable factor for the longevity: An association study in the Chinese population. J Genet. 2011;90:343-7.
Laws SM, Hone E, Gandy S, Martins RN. Expanding the association between the APOE gene and the risk of Alzheimer´s disease: Possible roles for APOE promoter polymorphisms and alterations in APOE transcription. J Neurochem. 2003;84:1215-36. http://dx.doi.org/10.1046/j.1471-4159.2003.01615.x
Mahley RW, Innerarity TL, Rall SC Jr, Weisgraber KH. Plasma lipoproteins: Apolipoprotein structure and function. J Lipid Res. 1984;25:1277-94.
Greenow K, Pearce NJ, Ramji DP. The key role of apolipoprotein E in atherosclerosis. J Mol Med (Berl). 2005;83:329-42.
Anoop S, Misra A, Meena K, Luthra K. Apolipoprotein E polymorphism in cerebrovascular and coronary heart diseases. Indian J Med Res. 2010;132:363-78.
Gregorio ML, Pinhel MA, Sado CL, Longo GS, Oliveira FN, Amorim GS, et al . Impact of genetic variants of apolipoprotein E on lipid profile in patients with Parkinson´s disease. Biomed Res Int. 2013;2013:641515. http://dx.doi.org/10.1155/2013/641515
Fei M, Jianhua W. Apolipoprotein e4-allele as a significant risk factor for conversion from mild cognitive impairment to Alzheimer´s disease: A meta-analysis of prospective studies. J Mol Neurosci. 2013;50:257-63. http://dx.doi.org/10.1007/s12031-012-9934-y
Loango N, Gallego ML, Restrepo B, Landázuri P . Diferencias de sexo, edad y lípidos plasmáticos asociadas al polimorfismo de la apolipoproteína E en un grupo de escolares de Quindío, Colombia. Biomédica. 2009;29:382- 91. http://dx.doi.org/10.7705/biomedica.v29i3.10
Hixson JM, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J Lipid Res. 1990;31:545-8.
Callas N, Poveda E, Baracaldo C, Hernández P, Castillo C, Guerra M. Genetic polymorphism of the E apolipoprotein in school age children: Comparison with levels of plasma lipids and apolipoproteins. Biomédica. 2007;27:526-36. http://dx.doi.org/10.7705/biomedica.v27i4.171
Marca V, Acosta O, Cornejo-Olivas M, Ortega O, Huerta D, Mazzetti P. Polimorfismo genético de la apolipoproteína E en una población peruana. Rev Peru Med Exp Salud Pública. 2011;28:589-94.
Singh PP, Singh M, Mastana SS. APOE distribution in world populations with new data from India and the UK. Ann Hum Biol. 2006;33:279-308. http://dx.doi.org/10.1080/03014460600594513
Fernández-Mestre MT, Yehirobi C, Montagnani S, Balbas O, Layrisse Z. Genetic variability of apolipoprotein E in different populations from Venezuela. Dis Markers. 2005;21:15-9. http://dx.doi.org/10.1155/2005/625182
Jaramillo-Correa JP1, Keyeux G, Ruiz-García M, Rodas C, Bernal J. Population genetic analysis of the genes APOE , APOB (3´ VNTR) and ACE in some black and Amerindian communities from Colombia. Hum Hered. 2001;52:14-33. http://dx.doi.org/10.1159/000053351
De Knijjf P, Johansen LG, Rosseneu M, Frants RR, Jesperson J, Havekes LM. Lipoprotein profile of a Greenland Inuit population: Influence of anthropometric variables, ApoE and A4 polymorphism, and lifestyle. Arterioscler Thromb. 1992;12:1371-9. http://dx.doi.org/10.1161/01.ATV.12.12.1371
Demarchi DA, Salzano FM, Altuna ME, Fiegenbaum M, Hill K, Hurtado AM, et al . APOE polymorphism distribution among native Americans and related populations. Ann Hum Biol. 2005;32:351-65. http://dx.doi.org/10.1080/03014460500097237
Ojeda-Granados C, Panduro A, Ramos-López O, Román S. Construyendo una dieta correcta con base en el genoma latino. Rev Endocrinol Nutr. 2013;21:84-92.
Lars B. Apolipoproteína E: ¿un candidato importante para la interacción entre genes y nutrientes? Department of Medicine, University of California. Fecha de consulta: 23 de marzo de 2005. Disponible en: http://www.siicsalud.com/dato/dat042/05222000.htm.
Berkinbayev S, Rysuly M, Mussayev A, Blum K, Baitasova N, Mussagaliyeva A, et al . Apolipoprotein gene polymorphisms (APOB, APOC111, APOE) in the development of coronary heart disease in ethnic groups of Kazakhstan. J Genet Syndr Gene Ther. 2014;5:216. http://dx.doi.org/10.4172/2157-7412.100021610.4172/2157-7412.1000216
Yin Y-W, Sun Q-Q, Zhang B-B, Hu A-M, Liu H-L, Wang Q, et al . Association between apolipoprotein E gene polymorphism and the risk of coronary artery disease in Chinese population: Evidence from a meta-analysis of 40 studies. PLoS One. 2013;8:e66924. http://dx.doi.org/10.1371/journal.pone.0066924
Arango VJ, Valencia A, Páez A, Montoya N, Palacio C, Arbeláez MP, et al . Prevalencia de variantes en el gen de la apolipoproteína E (APOE) en adultos de la población general del área urbana de Medellín (Antioquia). Rev Colomb Psiquiat. 2014;43:80-6.
Forero DA, Pinzón J, Arboleda GH, Yunis JJ, Álvarez C, Cataño N, et al . Analysis of common polymorphisms in angiotensin-converting enzyme and apolipoprotein E genes and human longevity in Colombia. Arch Med Res. 2006;37: 890-4. http://dx.doi.org/10.1016/j.arcmed.2006.04.001
Svobodova H, Kucera F, Stulc T, Vrablik M, Amartuvshin B, Altannavch TS, et al . Apolipoprotein E gene polymorphism in the Mongolian population. Folia Biol (Praha). 2007;53:138-42.
Torres AL, Guerra-Muñoz M, Segrera A, Wagner J, Alvarado M. Modulación de los niveles de lípidos y lipoproteínas por el polimorfismo de la apolipoproteína E en individuos sanos de Bogotá D.C. NOVA. 2005;3:31-6.
Celaya J, Rodríguez A, Michelle P, Arends A. Estudios de polimorfismos del gen ( APOE ) de la apolipoproteína-E (ApoE) y su relación con niveles elevados de colesterol total, lipoproteínas y triglicéridos séricos en niños de edad escolar. Soc Med Quir Hosp Emerg Pérez de León. 2007;38(Supl.1):9-26.
Alvim RO, Freitas SR, Ferreira NE, Santos PC, Cunha RS, Mill JG, et al . APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general population. Lipids Health Dis. 2010;9:128. http://dx.doi.org/10.1186/1476-511X-9-128
Zeljko HM, Skaric-Juric T, Narancic NS, Tomas Z, Baresic A, Salihovic MP, et al . E2 allele of the apolipoprotein E gene polymorphism is predictive for obesity status in Roma minority population of Croatia. Lipids Health Dis. 2011;10:9. http://dx.doi.org/10.1186/1476-511X-10-9.
Heidari MH, Foruzannia MH, Emami M. Apolipoprotein E gene polymorphism in Iranian coronary atherosclerosis patients candidate for coronary artery bypass graft. Iran J Basic Med Sci. 2013;16:841-4.
Castañeda M. Análisis de polimorfismos en los genes ADAM10 , BACE1 , NCSTN y APOE en pacientes con enfermedad de Alzheimer de tipo esporádico en Antioquia (2011-2013). Tesis de Maestría. Bogotá: Universidad Nacional de Colombia; 2013.
Liu M, Bian C, Zhang J, Wen F. Apolipoprotein E gene polymorphism and Alzheimer´s disease in Chinese popula tion: A meta-analysis. Sci Rep. 2014;4:4383. http://dx.doi. org/10.1038/srep04383
Yasen AL, Raber J, Miller JK, Piper BJ. Sex , but not apolipoprotein E polymorphism, differences in spatial performance in young adults. Arch Sex Behav. 2015;44:2219-26. http://dx.doi.org/10.1007/s10508-015-0497-1
Some similar items:
- Elizabeth Borrero, Gabriel Carrasquilla, Neal Alexander, Decentralization and health system reform: What is their impact on malaria incidence in Colombian municipalities? , Biomedica: Vol. 32 (2012): Suplemento 1, Malaria
- Yazmin Rocío Arias, Karime Osorio-Arango, Brayan Bayona, Guadalupe Ercilla, Mauricio Beltrán-Durán, Determination of HLA-A, -B and -DRB1 polymorphism in brain dead organ donors representative of the Colombian general population, 2007-2014 , Biomedica: Vol. 37 No. 2 (2017)
- Lucero Rengifo, Duverney Gaviria, Herman Serrano, APOE gene polymorphisms associated with Down syndrome in Colombian populations , Biomedica: Vol. 32 No. 2 (2012)
- Gabriel Bedoya, Jenny García, Patricia Montoya, Winston Rojas, Maria Eugenia Amézquita, Iván Soto, Maria Cecilia López, Jorge Ospina-Duque, Andrés Ruiz-Linares, Isonymy analysis between 2 populations in northwestern Colombia , Biomedica: Vol. 26 No. 4 (2006)
- Winston Rojas, Maria Antonieta Caro, Juan Guillermo Lopera, Omar Triana, Juan Carlos Dib, Gabriel Bedoya, Analysis of polymorphisms in the trypanothione reductase and cruzipain genes in Colombian strains of Trypanosoma cruzi , Biomedica: Vol. 27 No. 1esp (2007): Enfermedad de Chagas
- Nelsy Loango, Martha Lucía Gallego, Beatriz Restrepo, Patricia Landázuri, Gender, age and plasma lipids differences associated with apolipoprotein E polymorphism in school children , Biomedica: Vol. 29 No. 3 (2009)
- Sandra Lorena Girón, Julio César Mateus, Fabián Méndez, Impact of an open waste disposal site on the occurrence of respiratory symptoms and on health care costs of children , Biomedica: Vol. 29 No. 3 (2009)
- Andrés Páez, Gloria Rey, Carlos Agudelo, Alvaro Dulce, Edgar Parra, Hernando Díaz-Granados, Damaris Heredia, Luis Polo, Outbreak of urban rabies transmitted by dogs in Santa Marta, northern Colombia , Biomedica: Vol. 29 No. 3 (2009)
- Patricia Escobar, Katherine Paola Luna, Indira Paola Hernández, César Mauricio Rueda, María Magdalena Zorro, Simon L. Croft, In vitro susceptibility of Trypanosoma cruzi strains from Santander, Colombia, to hexadecylphosphocholine (miltefosine), nifurtimox and benznidazole , Biomedica: Vol. 29 No. 3 (2009)
- Mauricio Beltrán, María Cristina Navas, María Patricia Arbeláez, Jorge Donado, Sergio Jaramillo, Fernando De la Hoz, Cecilia Estrada, Lucía del Pilar Cortés, Amalia de Maldonado, Gloria Rey, Seroprevalence of hepatitis B virus and human immunodeficiency virus infection in a population of multiply-transfused patients in Colombia , Biomedica: Vol. 29 No. 2 (2009)
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
